Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea.
D000577:Amides / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D001853:Bone Marrow / Q000187:drug effects; D002330:Carmustine / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D004357:Drug Synergism; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D008197:Lymph Node Excision; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013997:Time Factors; D014226:Triazenes / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity
D000577:Amides; D000970:Antineoplastic Agents; D007093:Imidazoles; D014226:Triazenes; D002330:Carmustine